“…Several characteristic conditions have been described that lead to activation of p53, which include the exhaustion of nucleotide pools [109], faults in cytoskeleton (altered polymerization of actin fibers and microtubules) [110][111][112], altered ribosome biogenesis [113], the condition of hypoxia and ischemia [14], hyperoxia [115], lack or deficit of certain growth factors and cytokines [116,117], altered adhesion and focal contacts [118], defective integrins [119], abnormal attachment of cells to a substrate (leading to the p53-dependent anoikis, or death of unattached cells) [120], accumulation of polyploid cells [32,121], formation of micronuclei [122], destruction or malformation of mitotic spindle [112], hypo-and hyperthermia [123,124], and exposure to nitric oxide (NO) [125]. These conditions induce characteristic modifications, either within the protein molecule of p53, or in the systems that control levels and activity of p53.…”